Recombinant Deoxyribonuclease I Eye Drops for Ocular Graft Versus Host Disease: Results of a Randomized Clinical Trial.
Saved in:
| Title: | Recombinant Deoxyribonuclease I Eye Drops for Ocular Graft Versus Host Disease: Results of a Randomized Clinical Trial. |
|---|---|
| Authors: | Mun CS; Corneal Translational Biology Laboratory (C.S.M., B.S., N.A., J.M., C.K., T.S., A.P., S.J.), Department of Ophthalmology and Visual Sciences; Center for Clinical and Translational Science (Y.-F.C.); and Department of Pharmacy Practice (M.A.S.), University of Illinois at Chicago, Chicago, IL., Surenkhuu B, Chen YF, Atassi N, Mun J, Kim C, Sheth T, Sarwar MA, Pradeep A, Jain S |
| Source: | Eye & contact lens [Eye Contact Lens] 2024 May 01; Vol. 50 (5), pp. 233-240. Date of Electronic Publication: 2024 Feb 23. |
| Publication Type: | Journal Article; Randomized Controlled Trial; Clinical Trial, Phase I; Clinical Trial, Phase II |
| Journal Info: | Publisher: Lippincott Williams & Wilkins Country of Publication: United States NLM ID: 101160941 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1542-233X (Electronic) Linking ISSN: 15422321 NLM ISO Abbreviation: Eye Contact Lens Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| ISSN: | 1542-233X |
|---|---|
| DOI: | 10.1097/ICL.0000000000001078 |
